Concorde Asset Management, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1631773 ANN ARBOR, MI

Position in GILD

as of Jun 30, 2026 · filed Aug 18, 2026 Compact

Position Value

$208,840

-$26,974 QoQ

Shares Held

1,653

-2.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.26%

of 13F equity value

Holder Rank

#1,897

of 2,266 holders

Holding Since

Mar 2021

8 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Concorde Asset Management, LLC holds $2,975,283 across 6 Drug Manufacturers - General names. GILD ranks #6 (7.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	652	$782,028
2	JNJ	Johnson & Johnson	2,819	$715,941
3	ABBV	AbbVie Inc.	2,581	$649,482
4	AMGN	Amgen Inc	856	$309,974
5	PFE	Pfizer Inc	12,833	$309,018
6	GILD	Gilead Sciences, Inc. This page	1,653	$208,840

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$208,840	1,653	-2.3%	Shares	Sole	2026-08-18
2026-03-31	$235,814	1,692	-11.9%	Shares	Sole	2026-06-01
2025-12-31	$235,660	1,920	-25.4%	Shares	Sole	2026-02-13
2025-09-30	$285,714	2,574	+1.5%	Shares	Sole	2025-11-14
2025-03-31	$284,270	2,537	-1.6%	Shares	Sole	2025-05-15
2024-12-31	$238,222	2,579	+2.3%	Shares	Sole	2025-02-13
2024-09-30	$211,276	2,520	-22.4%	Shares	Sole	2024-11-12
2021-03-31	$209,917	3,248	—	Shares	Sole	2021-04-27
No filing history on record for this holder in this stock.